{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T03:24:19Z","timestamp":1700537059310},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1999,12,1]],"date-time":"1999-12-01T00:00:00Z","timestamp":944006400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[1999,12]]},"DOI":"10.1186\/bcr13","type":"journal-article","created":{"date-parts":[[2002,9,26]],"date-time":"2002-09-26T08:07:27Z","timestamp":1033027647000},"source":"Crossref","is-referenced-by-count":8,"title":["The pathology of familial breast cancer: Clinical and geneticcounselling implications of breast cancer pathology"],"prefix":"10.1186","volume":"1","author":[{"given":"Fiona","family":"Lalloo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D Gareth R","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1999,12,1]]},"reference":[{"key":"13_CR1","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/oxfordjournals.aje.a115616","volume":"131","author":"EB Claus","year":"1990","unstructured":"Claus EB, Risch NJ, Thompson WD: Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol. 1990, 131: 961-972.","journal-title":"Am J Epidemiol"},{"key":"13_CR2","first-page":"1457","volume":"57","author":"D Ford","year":"1995","unstructured":"Ford D, Easton DF, Peto J: Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet. 1995, 57: 1457-1462.","journal-title":"Am J Hum Genet"},{"key":"13_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1056\/NEJM199601183340301","volume":"334","author":"AA Langston","year":"1996","unstructured":"Langston AA, Malone KE, Thompson JD, Daling JR, Ostrander EA: BRCA1 mutations in a population-based sample of young women with breast cancer. N Engl J Med. 1996, 334: 137-142. 10.1056\/NEJM199601183340301.","journal-title":"N Engl J Med"},{"key":"13_CR4","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/ng0797-210","volume":"16","author":"D Easton","year":"1997","unstructured":"Easton D: Breast cancer genes-what are the real risks? . Nature Genet. 1997, 16: 210-211.","journal-title":"Nature Genet"},{"key":"13_CR5","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1126\/science.2270482","volume":"250","author":"JM Hall","year":"1990","unstructured":"Hall JM, Lee MK, Newman B, et al: Linkage of early-onset familial cancer to chromosme 17q21. Science. 1990, 250: 1684-1689.","journal-title":"Science"},{"key":"13_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D, et al: A strong candidate for the breast and ovarian cancer susceptibility gene, BRCA1. Science. 1994, 266: 66-71.","journal-title":"Science"},{"key":"13_CR7","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1126\/science.8091231","volume":"265","author":"R Wooster","year":"1994","unstructured":"Wooster R, Neuhausen SL, Mangion J, et al: Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science. 1994, 265: 2088-2090.","journal-title":"Science"},{"key":"13_CR8","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/378789a0","volume":"378","author":"R Wooster","year":"1995","unstructured":"Wooster R, Bignell G, Lancaster J, et al: Identification of the breast cancer gene BRCA2. Nature. 1995, 378: 789-791. 10.1038\/378789a0.","journal-title":"Nature"},{"key":"13_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bjc.1997.328","volume":"76","author":"JM Varley","year":"1997","unstructured":"Varley JM, Evans DGR, Birch JM: Li-Fraumeni Syndrome: a molecular and clinical review. Br J Cancer. 1997, 76: 1-14.","journal-title":"Br J Cancer"},{"key":"13_CR10","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1038\/sj.bjc.6690265","volume":"79","author":"JM Boyle","year":"1999","unstructured":"Boyle JM, Greaves MJ, Camplejohn RS, et al: Radiation induced G(1) arrest is not defective in fibroblasts from Li-Fraumeni families without TP53 mutations. Br J Cancer. 1999, 79: 1657-1664. 10.1038\/sj.bjc.6690265.","journal-title":"Br J Cancer"},{"key":"13_CR11","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/hmg\/7.3.507","volume":"7","author":"DJ Marsh","year":"1998","unstructured":"Marsh DJ, Coulon V, Lunetta KL, et al: Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutations. Hum Mol Genet. 1998, 7: 507-516. 10.1093\/hmg\/7.3.507.","journal-title":"Hum Mol Genet"},{"key":"13_CR12","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/34432","volume":"391","author":"A Hemminki","year":"1998","unstructured":"Hemminki A, Markie D, Tomlinson I, et al: A serine\/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature. 1998, 391: 184-187. 10.1038\/34432.","journal-title":"Nature"},{"key":"13_CR13","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M, et al: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet. 1998, 62: 676-689. 10.1086\/301749.","journal-title":"Am J Hum Genet"},{"key":"13_CR14","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1002\/(SICI)1097-0142(19981201)83:11<2335::AID-CNCR13>3.0.CO;2-N","volume":"83","author":"JE Armes","year":"1998","unstructured":"Armes JE, Egan AJM, Southey MC, et al: The histologic phenotypes of breast carcinoma occuring before age 40 years in women with and without BRCA1 and BRCA2 germline mutations. Cancer. 1998, 83: 2335-2345. 10.1002\/(SICI)1097-0142(19981201)83:11<2335::AID-CNCR13>3.3.CO;2-E.","journal-title":"Cancer"},{"key":"13_CR15","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/S0140-6736(96)10109-4","volume":"349","author":"Breast Cancer Linkage Consortium","year":"1997","unstructured":"Breast Cancer Linkage Consortium : Pathology of familial breast cancer: differences between cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet. 1997, 349: 1505-1510. 10.1016\/S0140-6736(96)10109-4.","journal-title":"Lancet"},{"key":"13_CR16","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1126\/science.2270486","volume":"250","author":"MH Skolnick","year":"1990","unstructured":"Skolnick MH, Cannon-Albright L, Goldgar DE, et al: Inheritance of proliferative breast disease in breast cancer kindreds. Science. 1990, 250: 1715-1720.","journal-title":"Science"},{"key":"13_CR17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1056\/NEJM198501173120303","volume":"312","author":"WD Dupont","year":"1985","unstructured":"Dupont WD, Page DL: Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985, 312: 146-151.","journal-title":"N Engl J Med"},{"key":"13_CR18","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1002\/bjs.1800811038","volume":"81","author":"DE Porter","year":"1994","unstructured":"Porter DE, Cohen BB, Wallace MR, et al: Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation families linked to BRCA1 on chromosome 17q12-21. Br J Surg . 1994, 81: 1512-1515.","journal-title":"Br J Surg"},{"key":"13_CR19","first-page":"2465","volume":"3","author":"W Foulkes","year":"1997","unstructured":"Foulkes W, Wong N, Brunet JS, et al: Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer. Clin Cancer Res. 1997, 3: 2465-2469.","journal-title":"Clin Cancer Res"},{"key":"13_CR20","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/S0140-6736(97)07065-7","volume":"351","author":"LC Verhoog","year":"1998","unstructured":"Verhoog LC, Brekelmans CTM, Seynaeve C, et al: Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1. Lancet. 1998, 351: 316-321. 10.1016\/S0140-6736(97)07065-7.","journal-title":"Lancet"},{"key":"13_CR21","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/(SICI)1097-0142(19960215)77:4<697::AID-CNCR16>3.0.CO;2-W","volume":"77","author":"JN Marcus","year":"1996","unstructured":"Marcus JN, Watson P, Page DL: Hereditary breast cancer. Pathobiology, prognosis and BRCA1 and BRCA2 linkage. Cancer. 1996, 77: 697-709. 10.1002\/(SICI)1097-0142(19960215)77:4<697::AID-CNCR16>3.0.CO;2-W.","journal-title":"Cancer"},{"key":"13_CR22","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/jnci\/91.3.259","volume":"91","author":"JS Lee","year":"1999","unstructured":"Lee JS, Wacholder S, Struewing JP, et al: Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst. 1999, 91: 259-263. 10.1093\/jnci\/91.3.259.","journal-title":"J Natl Cancer Inst"},{"key":"13_CR23","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1200\/JCO.1998.16.7.2417","volume":"16","author":"TS Frank","year":"1998","unstructured":"Frank TS, Manley SA, Olufunmilayo I, et al: Sequence analysis of BRCA1 and BRCA2: correlations of mutations with family history and ovarian cancer risk. J Clin Oncol. 1998, 16: 2417-2425.","journal-title":"J Clin Oncol"},{"key":"13_CR24","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1136\/jmg.35.2.116","volume":"35","author":"J Chang-Claude","year":"1998","unstructured":"Chang-Claude J, Dong J, Schmidt S, et al: Using gene carrier probability to select high risk families for identifying germline mutations in breast cancer susceptibility genes. J Med Genet. 1998, 35: 116-121.","journal-title":"J Med Genet"},{"key":"13_CR25","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/jnci\/91.11.943","volume":"91","author":"J Peto","year":"1999","unstructured":"Peto J, Collins N, Barfoot R, et al: Prevalence of BRCA1 and BRCA2 gene mutations in patients with early onset breast cancer. J Natl Cancer Inst. 1999, 91: 943-949. 10.1093\/jnci\/91.11.943.","journal-title":"J Natl Cancer Inst"},{"key":"13_CR26","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1001\/jama.1996.03530480027036","volume":"275","author":"C Lerman","year":"1996","unstructured":"Lerman C, Narod S, Schulman K, et al: BRCA1 testing in families with hereditary breast-ovarian cancer: a prospective study of patient decision making and outcomes. JAMA. 1996, 275: 1885-1892. 10.1001\/jama.275.24.1885.","journal-title":"JAMA"},{"key":"13_CR27","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1200\/JCO.1998.16.6.2045","volume":"16","author":"E Chabner","year":"1998","unstructured":"Chabner E, Nixon A, Gelman R, et al: Family history and treatment outcomes in young women after breast-conserving surgery and radiation therapy for early-stage breast cancer. J Clin Oncol . 1998, 16: 2045-2051.","journal-title":"J Clin Oncol"},{"key":"13_CR28","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/ajmg.1320560305","volume":"56","author":"DF Easton","year":"1995","unstructured":"Easton DF, Ford D, Bishop DT: Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet. 1995, 56: 265-271.","journal-title":"Am J Hum Genet"},{"key":"13_CR29","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/(SICI)1097-0215(19961211)68:6<693::AID-IJC1>3.0.CO;2-Z","volume":"68","author":"L Tab\u00e1r","year":"1996","unstructured":"Tab\u00e1r L, Larsson LG, Anderson I, et al: Breast-cancer screening with mamography in women aged 40-49 years. Int J Cancer. 1996, 68: 693-699. 10.1002\/(SICI)1097-0215(19961211)68:6<693::AID-IJC1>3.3.CO;2-P.","journal-title":"Int J Cancer"},{"key":"13_CR30","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1016\/S0140-6736(99)90074-0","volume":"353","author":"K Dickersin","year":"1999","unstructured":"Dickersin K: Breast screening inwomen aged 40-49 years: what next?. Lancet. 1999, 353: 1896-1897. 10.1016\/S0140-6736(99)90074-0.","journal-title":"Lancet"},{"key":"13_CR31","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0959-8049(98)00005-7","volume":"34","author":"F Lalloo","year":"1998","unstructured":"Lalloo F, Boggis CRM, Evans DGR, et al: Screening by mammography, women with a family history of breast cancer. Eur J Cancer. 1998, 34: 937-940. 10.1016\/S0959-8049(98)00005-7.","journal-title":"Eur J Cancer"},{"key":"13_CR32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0960-9776(98)90053-4","volume":"7","author":"P M\u00f6ller","year":"1998","unstructured":"M\u00f6ller P, Maehle L, Heimdal K, et al: Prospective findings in breast cancer kindreds: annual incidence rates according to age, stage at diagnosis, mean sojourn time, and incidence rates for contralateral cancer. Breast. 1998, 7: 55-59. 10.1016\/S0960-9776(98)90053-4.","journal-title":"Breast"},{"key":"13_CR33","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/S0959-8049(97)00365-1","volume":"34","author":"J Kollias","year":"1998","unstructured":"Kollias J, Sibbering DM, Blamey RW, et al: Screening women aged less than 50 years with a family history of breast cancer. Eur J Cancer. 1998, 34: 878-883. 10.1016\/S0959-8049(97)00365-1.","journal-title":"Eur J Cancer"},{"key":"13_CR34","volume-title":"Breast Cancer Screening: Report to the Health Ministers of England, Wales, Scotland and Northern Ireland. London: HMSO","author":"APM Forrest","year":"1986","unstructured":"Forrest APM: . Breast Cancer Screening: Report to the Health Ministers of England, Wales, Scotland and Northern Ireland. London: HMSO. 1986"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr13.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/bcr13\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr13.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,31]],"date-time":"2017-12-31T19:21:19Z","timestamp":1514748079000},"score":1,"resource":{"primary":{"URL":"http:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999,12]]}},"alternative-id":["13"],"URL":"https:\/\/doi.org\/10.1186\/bcr13","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,12]]},"article-number":"48"}}